Search results

Purpose: The aim of this study was to identify the knowledge and awareness about human papilloma virus (HPV) and human papilloma virus (HPV) vaccine of women in reproductive age. Material and Methods: The study covered 294 women aged between 15 and 49. A questionnaire was prepared by the researchers based on the literature review. Results: The mean age of the participants was 30.5 +/- 8.9 years. Only 24.5% had heard about HPV infection and 28.2% had heard HPV vaccine. Of the participants, 188 (63.9%) got zero point from the knowledge questions. Conclusion: This study indicates that the women who apply primary care units have low knowledge levels; it is apperent that personal and social education is needed. Paying importance to patient education on HPV and cervical cancer in primary care health politics will increase knowledge and awareness for HPV infection and HPV vaccination.

INTRODUCTION: Human papilloma virus (HPV) is a renowned cause of cervical cancer, which has resulted in high mortality of individuals. Cervical cancer could be reduced by screening and HPV vaccination. This study investigated knowledge, attitudes and perceptions of parents towards HPV vaccines in Ibadan, South-West L.G.A, Oyo State, Nigeria. METHODS: A cross-sectional descriptive design was used with a multi-stage sampling technique to select 186 parents from Ibadan South-West local government area of Oyo state. A validated structured questionnaire (r=0.78) was used for data collection. RESULTS: The mean age of the respondents was 30.2 years. The parents had good knowledge of the HPV vaccine (mean=3.12) and most had a high level of knowledge (98.9%). Parents demonstrated negative attitude (mean=2.97) and positive perception to HPV vaccines. Major factors affecting their attitude towards the uptake of HPV vaccines were: finance (86%), level of education (81%), distance to health facilities (83%), inadequate knowledge about the vaccine (89%), fear of promiscuity (82%), and concern about adverse effect (80%). CONCLUSIONS: Factors responsible for a negative attitude were the high cost, distance from vaccination site, inadequate knowledge, fear of subsequent adolescent promiscuity and concern about adverse effects. In light of the benefits of HPV vaccination, the Nigerian government should make HPV vaccines available, affordable, and accessible to the public.

Introduction: Human Papilloma Virus (HPV) has many different epidemiological, social and political aspects. The aim of this study was to determine the research priorities according to the necessary aspects of HPV in Iran. Methods: The national and international databases were searched to obtain the published articles regarding HPV in Iran. All Epidemiologic studies were included in this review to assess research priorities. Results: Of 148 studies involving 14,661 participants, the most studies were conducted in Tehran (44.75%) province. Measuring prevalence of HPV (n=63, 42.5%), diagnosis of HPV by molecular techniques (n=52, 35.1%), Knowledge, Attitude and Practice studies (KAP) (n=13, 8.7%), vaccine efficacy (n=8, 5.4%), cost and cost effectiveness analysis (n=4, 2.7%), co-infection of HPV and sexually transmitted diseases (n=5, 3.3%) were the frequent aims of the included studies. Sixty percent (n=57) of the studies were conducted in clinical patients including patients with cervical cancer (n=30, 52.6%), patients with prostate cancer/Benign Prostate Hyperplasia (n=6, 10.5%), and patients with Esophageal carcinoma (n=5, 8.7%). Conclusion: According to our results, the high-risk groups such as female sex workers, injecting drug users and prisoners are in priority for research in the field of HPV. Despite ample epidemiologic studies on prevalence and association of HPV with specific cancers, evidence towards effectiveness and cost-benefits of HPV vaccination is required to prevent the infection and its complicated clinical consequences.

Bill 70 (HPV Vaccine Act) was presented to the Nova Scotia House of Assembly with the aim of expanding the current Nova Scotia school-based HPV vaccination program to include males. In recent years, increased awareness of HPV and HPV-caused cancers has led to the implementation of school-based female HPV vaccination programs across Canada. Changing guidelines, based on recent evidence, suggest that males should also be included in these programs. Program expansion to include males aims to reduce the prevalence of HPV-causing cancers and their ensuing costs, to promote equal access to healthcare services, and to make Nova Scotia a leader in HPV prevention. Support from the Canadian public and high profile political actors along with pressure from other provinces and interest groups, including the Society of Obstetricians and Gynaecologists of Canada, influenced the passing of the HPV Vaccine Act. In order to implement this reform, the provincial financial commitment to the previous HPV program was expanded to cover the cost of male vaccination. Le projet de loi 70 (Loi sur les vaccins contre le papillomavirus), dont l'objet est d'étendre aux garçons le programme de vaccination contre le papillomavirus humain (PVH) en vigueur actuellement dans les écoles de Nouvelle Écosse, a été présenté devant l'Assemblée parlementaire de la province. La prise de conscience récente du rôle du PVH comme facteur de risqué dans de nombreux cancers a conduit à la mise en place de programmes de vaccination scolaires pour les filles partout au Canada. Des données empiriques récentes ont conduit à modifier les recommandations de pratiques pour ouvrir ces programmes aux garçons. L'objectif d'une telle ouverture des programmes est de diminuer la prévalence (et les coûts) des cancers provoqués par le PVH, ainsi que de renforcer l'égalité d'accès aux soins et de placer la Nouvelle Écosse à la pointe de la prévention du PVH. Une opinion publique canadienne favorable, ainsi que le renfort d'acteurs politiques majeurs et la pression venue d'autres provinces et de groupes d'opinion, comme la Société des Obstétriciens et Gynécologues du Canada, ont contribué au vote de la loi sur la vaccination PVH. La province a augmenté son engagement financier dans le programme PVH afin de couvrir le coût des vaccins pour les garçons.

Human papilloma virus (HPV) is a viral agent whose transmission occurs mainly by sexual means. It causes different pathological conditions in both males and females, ranging from benign pathologies up to cancers. The introduction of vaccination has certainly had a major impact in terms of reducing the incidence of both HPV infections and diseases but in the European Union and the European Economic Area (EU/EEA) there are still about more than 13,000 deaths due to cervical cancer each year. To date in Europe and in Italy there are three vaccines available (bi-, tetra-, and nonvalent vaccines). The vaccination campaign started irregularly in Europe and Italy in 2007, with pre-adolescent girls as the primary target. Later, other cohorts were introduced such as 12-year-old boys, additional cohorts of > ; 25-year-old women, women who already underwent cervical surgery and other subjects entitled to free vaccination. The COVID-19 pandemic has strongly impacted on public health services, particularly on vaccinations that, especially during the first pandemic phase, have been often delayed and/or canceled. The most affected vaccinations by the pandemic have been the non-mandatory ones, particularly those addressing the adolescent and adult population, such as immunization against papillomavirus. To date the achievement of the coverage target set by the Italian National Immunization Plan (NIP) has not yet been achieved. The aim of this work is to summarize the current situation in Italy and to discuss the strategies that have been implemented to increase overall vaccination coverage rates.

Background: The human papilloma virus (HPV), a principal factor in the development of cervical cancer, is identified as one of the most widespread sexually transmitted infections, leading to a variety of conditions globally, from warts to cancer. It is estimated that 75% of people worldwide will contract an HPV infection at some point in their lives. Vaccination against HPV serves as an important preventive measure to reduce the rates of cervical cancer.
Objective: This study assessed knowledge, attitude of mothers toward HPV vaccine uptake in
Local communities in Edo State Nigeria.
Methods: A cross-sectional study utilizing a descriptive approach was carried out with 350 participants, chosen through simple random sampling. Information was gathered via questionnaires conducted by researchers and was processed with the Statistical Package for the Social Sciences (SPSS), version 25. To examine the relationships between variables, the Fisher's exact test was employed, with statistical significance determined by a P-value < 0.05.
Results: The average age of those surveyed was 40.4 years, with a standard deviation of 10.1 years. A mere 28.3% (44 respondents) had adequate knowledge about HPV and its vaccine. A significant portion (80%) exhibited a negative attitude toward receiving the HPV vaccine. There was a noticeable statistical correlation between the respondents' age and their awareness of HPV (with a p-value of 0.019) as well as between their employment status and their knowledge about HPV (p-value = 0.002). The primary reason cited by participants for not getting the HPV vaccine was its lack of availability.
Conclusion: Knowledge and uptake of HPV vaccination among the respondents were poor.
Majority also had negative attitude towards uptake of the vaccine.

Democratic access to scientific evidence contributes to the freedom of individuals to make informed decisions regarding scientific findings that affect their lives. In the case of the human papilloma virus (HPV), which causes cervical cancer, a debate exists regarding preventing HPV infection that is not supported by evidence-based interventions. For instance, there are positions both in favor of and against an HPV vaccine that are not evidence-based, thus preventing women from deciding freely whether to be vaccinated. Based on a communicative approach, this article describes the use of communicative focus groups and communicative daily life stories in which the researcher shares up-to-date information on HPV prevention, particularly through vaccination and screening, with high-schoolgirls in an urban context in Spain. Through the focus groups and daily life stories, the young women evaluated the impact of evidence-based dialogues, which could increase their opportunities to make free choices regarding the HPV vaccine and other medicines.

Background: Human papilloma virus is a causative agent of cervical cancer. Hence,vaccination against HPV is an important mode of primary prevention against cervical cancer. Two vaccines against HPV have been approved and recommended for use in India. However the availability of these vaccines is hardly known and seldom utilised even among the medical fraternity.Aims and Objectives: This study aims to find out the awareness about HPV vaccination among medical students of Andhra Medical College, India. Results of this study will help in assessing the need for awareness programs among health care professionals regarding this important public health issue. Materials and Methods: An observational descriptive study was conducted to know the awareness of HPV infection and vaccination among medical students of a government medical college at Visakhapatnam in Andhra Pradesh. A pretested questionnaire was administered to students of final MBBS Part 1 and final MBBS part 2. Results were analyzed in MS excel and the statistical significance of difference in knowledge between males and females was assessed. Results: Overall, the level of awareness reported was 54.5%. Females had slightly better knowledge than males. Students of final year Part 2 had better knowledge the Final year part 1. The most commonly cited source of information was medical education and the most important factor that deterred subjects from receiving/advising HPV vaccination was lack of knowledge. Conclusion: There exists a large gap in knowledge regarding HPV vaccination. Addressing this gap is necessary if we want to decrease the burden of cervical cancer in India. Medical students, health care providers should be sensitized first and then we should reach out to the public.Asian Journal of Medical Sciences Vol.7(4) 2016 64-67

Abstract Background Knowledge of the distribution of human papillomavirus (HPV) genotypes among women with cervical lesion and in invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. There is no published data concerning HPV and cervical abnormalities in Sudan. This study aimed to define the prevalence of HPV and its subtypes in the cervical smears of women presenting with gynecological complains at Omdurman Military Hospital, Sudan. During the period between March 2003 and April 2004, 135 cervical smears collected from these women, were screened using cytological techniques, and analysed by PCR for (beta)-globin and HPV DNA using gel electrophoresis and ELISA. Results Of these 135 smears, there were 94 (69.3%) negative, 22 (16.3%) positive for inflammation, 12(8.9) mild dyskaryosis, 5 (3.7) moderate dyskaryosis and 2 (1.8) severe dyskaryosis. There were 60.7% ß. globin positive samples for HPV indicating DNA integrity. HPV DNA was identified in three samples (2.2%) by gel electrophoresis and. was positive in four samples (2.9%) as single and multiple infections by PCR-ELISA. The high risk HPV types 16 and 58 were identified in one sample as a mixed infection. The low risk HPV types 40 and 42 were also found as a mixed infection in another patient. HPV types 58 and 42 were identified in the other two patients. Conclusion HPV type distribution in Sudan appears to differ from that in other countries. The HPV genotypes identified were not associated with cancer.

"Die Kritische Diskursanalyse der aktuellen Debatte über die Impfung gegen Humane Papilloma Viren (HPV) zeigt, dass die als 'Impfung gegen Krebs' betitelte Kampagne von einer Medikalisierung und Pathogenisierung des weiblichen Körpers flankiert wird. Aus medizin- und geschlechtersoziologischer Perspektive ist festzustellen, dass die Neu-Konfiguration der Krankheit Krebs als Infektionskrankheit mit einer Neu-Konfiguration des Mädchenkörpers als behandlungsbedürftig und ansteckend einhergeht." (Autorenreferat)

The Italian National Immunization Plan (NIP) states that public health today aims at immunizing adolescents of both sexes for maximum protection against all HPV-related vaccine-preventable diseases. Nowadays, the vaccination offer to primary cohorts is reaffirmed with continued free vaccination up to at least 26 years of age for females and up to at least 18 years of age for males. The Italian NIP 2023–2025 recommends HPV vaccination for at-risk categories, including individuals with HIV, men who have sex with men (MSM), women treated for intermediate- or high-grade lesions, and travelers. Catch-up vaccination is recommended for women at least up to 26 years of age, also using the appropriate occasion of the call for the first screening for the prevention of cervical cancer as an opportunity for vaccination, and for men at least up to and including 18 years of age if they have not been previously vaccinated or have not completed the vaccination cycle. In summary, the Italian vaccination offer has been extended to additional cohorts in order to reduce the burden of HPV-related diseases and to improve vaccination coverage of the Italian population.